Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
ZANTAC save search
Sanofi Agrees to Settle 4,000 Zantac Cancer Lawsuits in US State Courts
Published: 2024-04-04 (Crawled : 13:00) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 1.18%
H: 0.0%
C: 0.0%
state cancer sanofi
AgEagle Aerial Systems Attends UMEX 2024 Together with FEDS to Showcase eBee VISION and TAC Drones Representing Its First Introduction to the Middle East Market
Published: 2024-02-01 (Crawled : 13:00) - globenewswire.com
UAVS | $0.6499 1.98% 0.0% 130K
|
Electronic Technology
|
| O: 2.64%
H: 1.29%
C: 0.71%
first drones market
Exelixis and Ipsen Announce Positive Results from Phase 3 CONTACT-02 Pivotal Trial Evaluating Cabozantinib in Combination with Atezolizumab in Metastatic Castration-Resistant Prostate Cancer
Published: 2023-08-21 (Crawled : 05:00) - globenewswire.com
TAK | News | $13.36 0.91% -0.52% 1.6M
|
Health Technology
|
| O: -0.4%
H: 0.6%
C: 0.47%
EXEL | $22.86 1.51% 1.49% 1.5M
|
Health Technology
|
| O: 0.28%
H: 1.32%
C: 0.99%
ntact-02 positive cancer trial results
Tribunal Rejects Boehringer Ingelheim’s Liabilities Against Sanofi for Zantac
Published: 2023-06-20 (Crawled : 00:00) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 1.71%
H: 0.0%
C: 0.0%
sanofi
Press Release: Sanofi prevails in Zantac arbitration initiated by Boehringer Ingelheim
Published: 2023-06-20 (Crawled : 06:00) - globenewswire.com
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 1.71%
H: 0.0%
C: 0.0%
sanofi initiated
Sanofi and GSK Defend Zantac in Wake of Renewed Attention Surrounding Lawsuits (Updated)
Published: 2022-08-12 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.12%
H: 4.27%
C: 4.27%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 4.64%
H: 0.0%
C: 0.0%
sanofi
Sanofi and GSK Defend Zantac in Wake of Renewed Attention Surrounding Lawsuit...
Published: 2022-08-12 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.12%
H: 4.27%
C: 4.27%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 4.64%
H: 0.0%
C: 0.0%
sanofi
Facing Thousands of Zantac-Related Lawsuits, GSK and Sanofi See Mass Sell-Off...
Published: 2022-08-11 (Crawled : 16:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.45%
H: 0.18%
C: -1.47%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -10.3%
H: 0.0%
C: 0.0%
sanofi
FDA Updates and Press Announcements on NDMA in Zantac (ranitidine)
Published: 2021-07-01 (Crawled : 17:02) - fda.gov
PRGO | $30.06 -2.4% 0.0% 1.4M
|
Health Technology
|
| O: -0.48%
H: 2.41%
C: 2.37%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -0.27%
H: 0.36%
C: 0.08%
fda
Missing Emails Add Additional Layer to Sanofi's Zantac Recall Drama
Published: 2021-05-12 (Crawled : 05:00) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -0.46%
H: 0.95%
C: 0.12%
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.